Fresenius Kabi

Fresenius Kabi, a prominent subsidiary of the global healthcare group Fresenius, is a specialized company focused on essential medicines and technologies for infusion, transfusion, and clinical nutrition. Operating within the Pharmaceutical and Healthcare industries, Fresenius Kabi is committed to advancing patient care through innovative solutions. Established in 2007, the company has cultivated a robust global footprint, serving critical medical needs across diverse markets.

The company's extensive operational capacity is evidenced by its workforce of over 10,000 employees and a network of 37 international locations. This broad reach enables Fresenius Kabi to deliver vital healthcare products and services efficiently. Their dedication to fostering a skilled and motivated team is central to their mission. Further insights into the organizational structure and personnel can be gained by exploring Meet Fresenius Kabi's team, which highlights the expertise driving their global operations.

Financially, Fresenius Kabi reports significant revenue of $8.9B, reflecting its strong market presence and the demand for its specialized offerings. The product range is comprehensive, including critical items like clinical nutrition, infusion and transfusion technologies, oncology support, and parenteral nutrition. They also provide generic drugs, biosimilars, and advanced medical devices. For detailed financial performance metrics and investment insights, users can Explore financial highlights.